TREE NEWS update: A report released at the 2026 Brain-Computer Interface Conference in Beijing on May 21 shows China’s BCI industry is clustered in the Beijing-Tianjin-Hebei, Yangtze River Delta and Greater Bay Area city groups. The global count of BCI companies reached 1,175 in 2026, a rapid increase from 2025. Industry revenue currently comes mainly from research and medical fields, with many medical device products still in R&D, clinical trials and approval, while non-medical applications remain at an early stage.
China’s Brain-Computer Interface Industry Clusters in Three City Groups, Report Says
The clustering around three established city groups suggests China's BCI buildout is following the same geographic playbook as other deep-tech sectors, concentrating talent, capital and clinical infrastructure rather than spreading thinly. The disclosed revenue mix is the more telling detail: with medical devices still working through R&D, trials and approval, and non-medical uses early-stage, the industry's commercial base remains narrow despite the surge in company counts. Whether that pipeline converts into approved products, and whether non-medical applications mature beyond pilots, is the open question for gauging how much of this growth is durable.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.